Ok, so after posting I went back and re-read a bunch of the documents. I’m not sure about my interpretation exactly but I’m still not at all sure everything we need to know is accounted for in the summary...
Did anyone else notice the section... I think it was 6.1 or something where the vendor will stop using the name BioAmber?
The way that it reads, I don’t see any reason why the new company can’t be named BioAmber.
This has been one super-crazy ride.
I’m glad so many opposing views seem so absolutely certain of the outcome.
That must be really pleasant.
In my opinion, I don’t see anything that tells me one way or the other what will happen to share value because I don’t know how the new owners plan to fund the next phase.
GLTA BIOAQ!
News 
Market Data 
Discover 
AI
